# Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

> **NCT00866879** · PHASE4 · COMPLETED · sponsor: **Northwestern University** · enrollment: 275 (actual)

## Conditions studied

- Renal Transplant Rejection

## Interventions

- **DRUG:** Sirolimus
- **OTHER:** Demographic Data, Medical History, and Donor Data
- **PROCEDURE:** Blood Draws for Control Group
- **PROCEDURE:** Blood Draws for Experimental Group
- **PROCEDURE:** Donor Blood Draws
- **OTHER:** Donor Information
- **PROCEDURE:** Kidney Biopsy

## Key facts

- **NCT ID:** NCT00866879
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2017-12
- **Final completion:** 2019-03
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2019-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866879, "Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00866879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*